ATAC

EUIPO EUIPO 2018 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ATAC was filed as Word mark on 11/21/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/29/2021. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 017988594
Application date November 21, 2018
Publication date November 27, 2018
Entry date March 29, 2021
Expiration date November 21, 2028

Trademark owner

Gregor-Mendel-Straße 22
68526 Ladenburg
DE

Trademark representatives

Nürnberger Straße 19 95448 Bayreuth DE

Objection / Complaint

02/25/2019: Likelihood of confusion
Trademark
Applicant
Laboratoires Théa (société par actions simplifiée)
02/26/2019: Likelihood of confusion
Trademark
Applicant
Novartis AG

goods and services

5 Pharmaceutical preparations; Pharmaceuticals; Chemico-pharmaceutical preparations; Pharmaceutical preparations and substances; Pharmaceutical preparations for veterinary use; Chemical preparations for pharmaceutical purposes; Pharmaceutical preparations for human use; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Clinical diagnostic reagents; Diagnostic chemical reagents for medical use; Anti-cancer drugs; Compounds for treating cancer; Anti-cancer preparations; Anti-cancer preparations of chemical origin; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Chemotherapeutics; Antibodies; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression with agents including amatoxin
42 Pharmaceutical research services; Medical and pharmacological research services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Provision of research services; Scientific research; Medical research; Biomedical research services; Research relating to biotechnology; Research on the subject of pharmaceuticals; Consultancy relating to research in the field of pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of diagnostic preparations; Research and development in the field of biotechnology; Research and development for the pharmaceutical industry; Research and development services in the field of antibody technology; Research and development services in the field of antibodies; Laboratory services relating to the production of monoclonal antibodies; all the aforesaid services in the fields of oncology and/or immunosuppression
44 Pharmaceutical advice; Pharmaceutical services; Consultancy and information services relating to pharmaceutical products; all the aforesaid services in the fields of oncology and/or immunosuppression

Trademark history

Date Document number Area Entry
May 14, 2021 Change Representative, Published
May 13, 2021 RAW: Representative - Deletion of the representative, Published
September 21, 2020 Transfer / Change of address, Registered
December 17, 2018 Transfer / Change of address, Registered

ID: 11017988594